Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Trilipix

Last reviewed on RxList: 7/23/2020
Trilipix Side Effects Center

What Is Trilipix?

Trilipix (fenofibric acid) is a lipid regulating agent used to treat high cholesterol and high triglyceride levels. It is sometimes given together with other cholesterol-lowering medications. Trilipix is available in generic form.

What Are Side Effects of Trilipix?

Common side effects of Trilipix include:

Trilipix may rarely cause gallstones and liver problems. If you notice any of the following unlikely but serious side effects, tell your doctor:

Dosage for Trilipix

The dose of Trilipix ranges from 45 to 135 mg once daily, depending on the patient's condition. Dosage is individualized according to patient response.

What Drugs, Substances, or Supplements Interact with Trilipix?

Trilipix may interact with cyclosporine, blood thinners, diuretics (water pills), birth control pills or hormone replacement therapy, or beta-blockers. Tell your doctor all medications and supplements you use.

Trilipix During Pregnancy and Breastfeeding

Trilipix is not recommended for use during pregnancy. It may harm a fetus. It is unknown if this medication passes into breast milk. Breastfeeding while using this drug is not recommended.

Additional Information

Our Trilipix (fenofibric acid) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

SLIDESHOW

How to Lower Your Cholesterol & Save Your Heart See Slideshow
Trilipix Consumer Information

3 pharmacies near 20147 have coupons for Fibricor (Brand Names:Trilipix for 45MG)

CVS Pharmacy
CVS Pharmacy
$324.99

Est. Regular Price

$286.33

with free coupon

View Coupon
Walgreens
Walgreens
$324.99

Est. Regular Price

$288.32

with free coupon

View Coupon
Harris Teeter Pharmacy
Harris Teeter Pharmacy
$324.99

Est. Regular Price

$291.57

with free coupon

View Coupon

Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning in your eyes, skin pain, red or purple skin rash that spreads and causes blistering and peeling).

In rare cases, fenofibric acid can cause a condition that results in the breakdown of skeletal muscle tissue, leading to kidney failure. Call your doctor right away if you have unexplained muscle pain, tenderness, or weakness especially if you also have fever, unusual tiredness, or dark colored urine.

Also call your doctor at once if you have:

  • sharp stomach pain spreading to your back or shoulder blade;
  • loss of appetite, stomach pain just after eating a meal;
  • jaundice (yellowing of the skin or eyes);
  • fever, chills, weakness, sore throat, mouth sores, unusual bruising or bleeding;
  • chest pain, sudden cough, wheezing, rapid breathing, coughing up blood; or
  • swelling, warmth, or redness in an arm or leg.

Common side effects may include:

  • runny nose, sneezing; or
  • abnormal laboratory tests.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Trilipix (Fenofibric Acid Capsules)

QUESTION

What is cholesterol? See Answer
Trilipix Professional Information

SIDE EFFECTS

Clinical Trials Experience

Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.

Fenofibric acid is the active metabolite of fenofibrate. Adverse events reported by 2% or more of patients treated with fenofibrate and greater than placebo during double-blind, placebo-controlled trials are listed in Table 1. Adverse events led to discontinuation of treatment in 5.0% of patients treated with fenofibrate and in 3.0% treated with placebo. Increases in liver tests were the most frequent events, causing discontinuation of fenofibrate treatment in 1.6% of patients in double-blind trials.

Table 1: Adverse Events Reported by 2% or More of Patients Treated with Fenofibrate and Greater than Placebo During the Double-Blind, Placebo-Controlled Trials

BODY SYSTEM Adverse Event Fenofibrate*
(N = 439)
Placebo
(N = 365)
BODY AS A WHOLE
Abdominal Pain 4.6% 4.4%
Back Pain 3.4% 2.5%
Headache 3.2% 2.7%
DIGESTIVE
Nausea 2.3% 1.9%
Constipation 2.1% 1.4%
INVESTIGATIONS
Abnormal Liver Tests 7.5% 1.4%
Increased AST 3.4% 0.5%
Increased ALT 3.0% 1.6%
Increased Creatine Phosphokinase 3.0% 1.4%
RESPIRATORY
Respiratory Disorder 6.2% 5.5%
Rhinitis 2.3% 1.1%
*Dosage equivalent to 135 mg Trilipix

Urticaria was seen in 1.1% vs. 0%, and rash in 1.4% vs. 0.8% of fenofibrate and placebo patients respectively in controlled trials.

Clinical trials with Trilipix did not include a placebo-control arm. However, the adverse event profile of Trilipix was generally consistent with that of fenofibrate. The following adverse events not listed above were reported in ≥ 3% of patients taking Trilipix alone:

Gastrointestinal Disorders: Diarrhea, dyspepsia

General Disorders and Administration Site Conditions: Pain

Infections and Infestations: Nasopharyngitis, sinusitis, upper respiratory tract infection

Musculoskeletal and Connective Tissue Disorders: Arthralgia, myalgia, pain in extremity

Nervous System Disorders: Dizziness

Postmarketing Experience

The following adverse reactions have been identified during postapproval use of fenofibrate. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure: rhabdomyolysis, pancreatitis, renal failure, muscle spasms, acute renal failure, hepatitis, cirrhosis, anemia, asthenia, and severely depressed HDL-cholesterol levels. Photosensitivity reactions to fenofibrate have occurred days to months after initiation; in some of these cases, patients reported a prior photosensitivity reaction to ketoprofen.

Read the entire FDA prescribing information for Trilipix (Fenofibric Acid Capsules)

Related Resources for Trilipix

Read the Trilipix User Reviews »

© Trilipix Patient Information is supplied by Cerner Multum, Inc. and Trilipix Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

SLIDESHOW

How to Lower Your Cholesterol & Save Your Heart See Slideshow

Health Solutions From Our Sponsors

CONTINUE SCROLLING FOR RELATED SLIDESHOW